A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD
出版年份 2020 全文链接
标题
A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD
作者
关键词
-
出版物
Expert Review of Gastroenterology & Hepatology
Volume -, Issue -, Pages 1-8
出版商
Informa UK Limited
发表日期
2020-12-04
DOI
10.1080/17474124.2021.1860019
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
- (2020) Rod S. Taylor et al. GASTROENTEROLOGY
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
- (2020) Jean-François Dufour et al. GUT
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
- (2020) Giovanni Targher et al. GUT
- Nonalcoholic Steatohepatitis
- (2020) Adam C. Sheka et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Redefining fatty liver disease classification in 2020
- (2020) Luca Valenti et al. LIVER INTERNATIONAL
- What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’
- (2020) Yasser Fouad et al. LIVER INTERNATIONAL
- From NAFLD to MAFLD: when pathophysiology succeeds
- (2020) Herbert Tilg et al. Nature Reviews Gastroenterology & Hepatology
- Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease
- (2020) Angeliki Katsarou et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Redefining non-alcoholic fatty liver disease: what's in a name?
- (2020) The Lancet Gastroenterology & Hepatology Lancet Gastroenterology & Hepatology
- From NAFLD to MAFLD: Implications of a premature change in terminology
- (2020) Zobair M Younossi et al. HEPATOLOGY
- MAFLD vs NAFLD: Let the contest begin!
- (2020) Cristiana Bianco et al. LIVER INTERNATIONAL
- Comparison of MAFLD and NAFLD diagnostic criteria in real world
- (2020) Su Lin et al. LIVER INTERNATIONAL
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. Hepatology International
- MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
- (2020) Sakura Yamamura et al. LIVER INTERNATIONAL
- Redefining fatty liver disease: an international patient perspective
- (2020) Gamal Shiha et al. Lancet Gastroenterology & Hepatology
- The NAFLD‐MAFLD debate: Eminence vs evidence
- (2020) Yasser Fouad et al. LIVER INTERNATIONAL
- The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease
- (2020) Nahum Mendez-Sanchez et al. Lancet Gastroenterology & Hepatology
- Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa
- (2020) Gamal Shiha et al. Lancet Gastroenterology & Hepatology
- Noninvasive diagnosis of liver fibrosis in NAFLD: Tips tricks
- (2019) Floraine Zuberbuhler et al. Clinics and Research in Hepatology and Gastroenterology
- New dual peroxisome proliferator activated receptor agonist—Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence
- (2019) Upendra Kaul et al. Cardiovascular Diabetology
- Are Nonalcoholic Fatty Liver Disease and Alcoholic Fatty Liver Disease More Than Just Semantics?
- (2019) Mohammed Eslam et al. GASTROENTEROLOGY
- Non-alcoholic fatty liver disease: A growing public health problem in Turkey
- (2019) Eda Kaya et al. Turkish Journal of Gastroenterology
- Phase 3 drug pipelines in the treatment of NASH
- (2019) Yoshio Sumida et al. HEPATOLOGY RESEARCH
- Alcohol Use is Associated with Hepatic Steatosis Among Persons with Presumed Non-alcoholic Fatty Liver Disease
- (2019) Michelle T. Long et al. Clinical Gastroenterology and Hepatology
- Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Non‐alcoholic Fatty Liver Disease
- (2019) Fasiha Kanwal et al. HEPATOLOGY
- Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives
- (2019) Grazia Pennisi et al. International Journal of Environmental Research and Public Health
- Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis
- (2019) Mohammad Shadab Siddiqui et al. JOURNAL OF HEPATOLOGY
- Non-heavy drinking and worsening of non-invasive fibrosis markers in nonalcoholic fatty liver disease: A cohort study
- (2018) Yoosoo Chang et al. HEPATOLOGY
- Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future
- (2018) Ana Ruth Araújo et al. LIVER INTERNATIONAL
- Effect of alcohol consumption on survival in non-alcoholic fatty liver disease: a national prospective cohort study
- (2018) Kaveh Hajifathalian et al. HEPATOLOGY
- Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- (2018) Zobair Younossi et al. HEPATOLOGY
- Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Max G Griswold et al. LANCET
- Non-alcoholic fatty liver disease – A global public health perspective
- (2018) Zobair M. Younossi JOURNAL OF HEPATOLOGY
- Renaming schizophrenia: 5 × 5
- (2018) Sinan Guloksuz et al. Epidemiology and Psychiatric Sciences
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Current and future pharmacological therapies for NAFLD/NASH
- (2017) Yoshio Sumida et al. JOURNAL OF GASTROENTEROLOGY
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- (2017) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Treatment of NAFLD with diet, physical activity and exercise
- (2017) Manuel Romero-Gómez et al. JOURNAL OF HEPATOLOGY
- Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
- (2017) Brandon J Perumpail et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children
- (2016) David E. Kleiner et al. Clinics in Liver Disease
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- NAFLD and liver transplantation: Current burden and expected challenges
- (2016) Raluca Pais et al. JOURNAL OF HEPATOLOGY
- Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- (2016) Gregory Thomas Brown et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Alcohol consumption and risk of fatty liver disease: a meta-analysis
- (2016) Guoli Cao et al. PeerJ
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Time to Abandon NASH?
- (2015) Jean-François Dufour HEPATOLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Current efforts and trends in the treatment of NASH
- (2015) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2014) Giovanni Musso et al. PLOS MEDICINE
- Characteristics and diagnosis of NAFLD/NASH
- (2013) Etsuko Hashimoto et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Multivariate modelling of endophenotypes associated with the metabolic syndrome in Chinese twins
- (2010) Z. Pang et al. DIABETOLOGIA
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search